Главная
Study mode:
on
1
Introduction
2
Where is the need for investment
3
Twosided coin
4
Two different models
5
Why is philanthropy needed
6
The US government is constrained
7
The role of the smaller diseasebased nonprofits
8
Bright Edges mission
9
Monetization
10
Neuroscience
11
Compass Study
12
Unique Role
13
Business Models
14
The Challenge
15
The Infrastructure
16
HBS
17
MDA
18
Scientific Advisory Board
19
Difference between nonprofit and LLC model
20
Impact of philanthropy on fundraising
21
Impact investing
22
Ecosystem
23
Be a convener
Description:
Explore the innovative approaches nonprofits are taking to bridge the gap between academic discoveries and successful drug development in this 58-minute panel discussion. Learn about the challenges in translating lab research to patient treatments, including resource limitations and high failure rates. Discover how nonprofit organizations are uniquely positioned to tackle high-risk projects through mission-driven approaches. Gain insights from industry experts on topics such as investment needs, government constraints, the role of disease-specific nonprofits, and various business models. Understand the impact of philanthropy on fundraising and the importance of impact investing in the drug development ecosystem. Hear from leaders in healthcare, venture funding, and research foundations as they discuss strategies for redefining philanthropic drug discovery and ensuring no opportunity is missed in bringing life-saving treatments to patients.

Redefining Philanthropic Drug Discovery

Milken Institute
Add to list
0:00 / 0:00